Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 12.09
-0.34 (-2.74%)
Sep 11, 2026, 3:00 PM CST
SHA:600161 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,168 | 1,991 | 2,686 | 4,555 | 3,713 | 4,330 |
Cash & Short-Term Investments | 2,168 | 1,991 | 2,686 | 4,555 | 3,713 | 4,330 |
Cash Growth | 13.94% | -25.86% | -41.04% | 22.68% | -14.25% | 147.68% |
Accounts Receivable | 2,361 | 2,202 | 1,121 | 94.13 | 1,173 | 1,027 |
Other Receivables | 7.54 | 7.6 | 13.45 | 39.08 | 28.36 | 22.27 |
Receivables | 2,369 | 2,209 | 1,134 | 133.21 | 1,201 | 1,050 |
Inventory | 4,127 | 4,022 | 3,869 | 2,844 | 2,332 | 2,144 |
Other Current Assets | 77.89 | 49.58 | 33.4 | 36.53 | 24.87 | 22.27 |
Total Current Assets | 8,742 | 8,272 | 7,722 | 7,569 | 7,271 | 7,546 |
Property, Plant & Equipment | 5,872 | 5,906 | 5,848 | 4,886 | 4,055 | 2,631 |
Long-Term Investments | 133.85 | 143.2 | 143.2 | 146.06 | 146.06 | 146.06 |
Goodwill | 572.15 | 572.15 | 572.15 | 173.92 | 173.92 | 127.93 |
Other Intangible Assets | 942.61 | 880.47 | 917.05 | 686.88 | 441.63 | 370.99 |
Long-Term Deferred Tax Assets | 60.09 | 56.43 | 41.77 | 46.74 | 60.63 | 67.01 |
Long-Term Deferred Charges | 624.37 | 655.09 | 507.82 | 470.26 | 552.69 | 362.46 |
Other Long-Term Assets | 98.42 | 97.76 | 117.66 | 208.66 | 228.88 | 326.85 |
Total Assets | 17,045 | 16,583 | 15,870 | 14,188 | 12,929 | 11,578 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 101.47 | 81.36 | 81.45 | 179.1 | 69.39 | 73.7 |
Accrued Expenses | 161.1 | 153.87 | 170.46 | 168.69 | 163.21 | 150.02 |
Short-Term Debt | 69.8 | 77.12 | - | - | - | - |
Current Portion of Long-Term Debt | 14.67 | - | - | - | 112.99 | 108.15 |
Current Portion of Leases | - | 15.69 | 8.96 | 17.95 | 10.82 | 16.51 |
Current Income Taxes Payable | 156.4 | 79.51 | 148.21 | 61.85 | 73.79 | 44.86 |
Current Unearned Revenue | 210.28 | 177.89 | 213.19 | 357.26 | 292.72 | 215.31 |
Other Current Liabilities | 538.26 | 449.21 | 498.07 | 494.78 | 434.44 | 201.03 |
Total Current Liabilities | 1,252 | 1,035 | 1,120 | 1,280 | 1,157 | 809.58 |
Long-Term Debt | - | - | - | - | 253.75 | 366.25 |
Long-Term Leases | 67.74 | 68.01 | 44.86 | 24.42 | 25.62 | 18.01 |
Long-Term Unearned Revenue | 94.77 | 98.66 | 107.44 | 99.56 | 101.9 | 92.69 |
Long-Term Deferred Tax Liabilities | 58 | 64.22 | 62.44 | 28.85 | 30.87 | 20.14 |
Other Long-Term Liabilities | 1.24 | 1.24 | 1.24 | 1.24 | 4.1 | 4.1 |
Total Liabilities | 1,474 | 1,267 | 1,336 | 1,434 | 1,574 | 1,311 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,977 | 1,977 | 1,977 | 1,648 | 1,648 | 1,373 |
Additional Paid-In Capital | 2,463 | 2,463 | 2,463 | 2,793 | 2,793 | 3,067 |
Retained Earnings | 7,500 | 7,295 | 6,698 | 5,382 | 4,355 | 3,612 |
Comprehensive Income & Other | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 |
Total Common Equity | 11,940 | 11,735 | 11,139 | 9,823 | 8,795 | 8,052 |
Minority Interest | 3,632 | 3,581 | 3,394 | 2,932 | 2,560 | 2,215 |
Shareholders' Equity | 15,572 | 15,316 | 14,533 | 12,754 | 11,356 | 10,267 |
Total Liabilities & Equity | 17,045 | 16,583 | 15,870 | 14,188 | 12,929 | 11,578 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 152.21 | 160.82 | 53.82 | 42.37 | 403.17 | 508.92 |
Net Cash (Debt) | 2,016 | 1,830 | 2,632 | 4,513 | 3,310 | 3,821 |
Net Cash Growth | 12.32% | -30.46% | -41.68% | 36.34% | -13.38% | 303.40% |
Net Cash Per Share | 1.01 | 0.92 | 1.33 | 2.28 | 1.66 | 1.97 |
Filing Date Shares Outstanding | 1,888 | 1,977 | 1,977 | 1,977 | 1,977 | 1,977 |
Total Common Shares Outstanding | 1,888 | 1,977 | 1,977 | 1,977 | 1,977 | 1,977 |
Working Capital | 7,490 | 7,238 | 6,602 | 6,290 | 6,113 | 6,736 |
Book Value Per Share | 6.33 | 5.93 | 5.63 | 4.97 | 4.45 | 4.07 |
Tangible Book Value | 10,425 | 10,283 | 9,650 | 8,962 | 8,180 | 7,553 |
Tangible Book Value Per Share | 5.52 | 5.20 | 4.88 | 4.53 | 4.14 | 3.82 |
Buildings | - | 2,963 | 2,711 | 2,241 | 1,957 | 963.02 |
Machinery | - | 3,122 | 2,760 | 2,218 | 1,996 | 1,258 |
Construction In Progress | - | 2,177 | 2,478 | 2,044 | 1,532 | 1,623 |